TAM Receptor Regulation of Innate Immunity
TAM 受体对先天免疫的调节
基本信息
- 批准号:7994189
- 负责人:
- 金额:$ 46.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-01 至 2011-11-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAdultAgonistAllelesAntigen-Presenting CellsApoptoticAutoimmune DiseasesAutoimmunityB-Cell ActivationB-LymphocytesBacteriaBindingBiochemicalBiologicalCell Culture TechniquesCell membraneCell physiologyCellsChronicCultured CellsCytoskeletonDefectDendritic CellsDendritic cell activationDevelopmentDimerizationDiseaseExposure toEyeFamilyFeedbackFunctional disorderGasesGenesGeneticGoalsHealthHomoHumanImmuneImmune responseImmune systemIn VitroInfectionInflammationInflammatoryInflammatory ResponseInterventionInvadedKnock-outKnockout MiceLigandsLupusLymphatic DiseasesMediatingMethodsMolecularMusMutant Strains MiceNatural ImmunityNatural Killer CellsNormal CellNormal tissue morphologyPathway interactionsPhagocytosisPhenotypePlayProcessProductionProtein SProteinsReagentReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationRelative (related person)Rheumatoid ArthritisRoleSTAT1 geneSepsisSeriesSignal PathwaySignal TransductionSjogren&aposs SyndromeStructureStructure of retinal pigment epitheliumSystemSystemic Lupus ErythematosusT-LymphocyteTNF geneTo autoantigenToll-like receptorsVirusbasecytokinedesignembryonic stem cellextracellularhomologous recombinationimmune functioninhibitor/antagonistinsightmacrophagemembermutantnovelpathogenreceptorrecombinaseresearch studytherapeutic targettranscription factor
项目摘要
The experiments of this application are designed to elucidate the roles
that the TAM receptor tyrosine kinases - Tyro 3, Axl, and Mer - play in the homeostatic
regulation of innate immunity. We have discovered that these receptors, together with
their agonists Gas 6 and Protein S, are essential intrinsic inhibitors of the inflammatory
response to infection. Tyro 3, Axl, and Mer are expressed by macrophages and dendritic
cells (DCs). These cells respond to invading bacteria and viruses by producing a
panolpy of pro-inflammatory and inflammatory cytokines, which, while essential to the
defeat of pathogens, are also injurious to normal cells and tissues. If unchecked at the
end of the innate immune response, production of cytokines such as TNF-a leads to
chronic inflammatory disease and autoimmunity.
The proposed studies exploit a powerful set of genetic reagents - mutant mice that
lack the function of each of the receptors and of the activating ligands. As adults, these
mice display devastating immune deficits, including lymphoproliferation marked by
severe splenomegalogy and lymphadenopathy, systemic hyperactivation of both
antigen-presenting cells and of B and T lymphocytes, defects in Natural Killer cell
function, and broad-spectrum autoimmune disease. We will investigate the cellular and
molecular basis of these phenomena. We will determine the relative contributions of
Gas6 and Protein S to TAM receptor activation, and investigate the biochemical
mechanisms that underlie suppression of innate immune responses by TAM signaling.
We have found that a central mechanism of TAM-mediated suppression involves
activation of the transcription factor STAT1 - which is also initially required to activate
cytokine production. This sets up a classic negative feedback loop for the regulation of
inflammation. We will also elucidate the role that TAM receptors play in triggering the
phagocytosis and clearance of apoptotic cells, and dissect the extracellular and
intracellular components of the pathway through which the receptors receive and
transduce signals required for this process. Together, these studies will provide basic
insights into a new signaling system of critical importance to the regulation of immune
responses and the development of autoimmunity.
该应用程序的实验旨在阐明角色
TAM受体酪氨酸激酶-Tyro 3,Axl和Mer-在体内平衡中发挥作用
对先天免疫的调节。我们发现这些受体以及
它们的激动剂气体6和蛋白质S是炎症的必不可少的固有抑制剂
对感染的反应。 TYRO 3,AXL和MER由巨噬细胞和树突状表达
细胞(DC)。这些细胞通过产生A来应对入侵细菌和病毒
促炎和炎症细胞因子的全张,虽然对
病原体的失败也对正常细胞和组织有害。如果未选中
先天免疫反应的终结,细胞因子(例如TNF-A)的产生导致
慢性炎症性疾病和自身免疫性。
提出的研究利用了一组强大的遗传试剂 - 突变小鼠
缺乏每个受体和活化配体的功能。作为成年人,这些
小鼠表现出毁灭性免疫缺陷,包括以
严重的脾肿和淋巴结肿大,两者的全身性过度激活
抗原呈递细胞以及B和T淋巴细胞的自然杀伤细胞缺陷
功能和广谱自身免疫性疾病。我们将研究细胞和
这些现象的分子基础。我们将确定
GAS6和蛋白质S到TAM受体激活,并研究生化
通过TAM信号传导抑制先天免疫反应的机制。
我们发现TAM介导的抑制的中心机制涉及
转录因子STAT1的激活最初也需要激活
细胞因子产生。这为调节的经典负面反馈循环设置了
炎。我们还将阐明TAM受体在触发触发中的作用
凋亡和凋亡细胞清除率,并剖析细胞外和
受体接收的途径的细胞内成分
此过程需要传递信号。这些研究将共同提供基本
洞悉对免疫调节至关重要的新信号传导系统
反应和自身免疫的发展。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TAM receptors and the clearance of apoptotic cells.
- DOI:10.1111/j.1749-6632.2010.05744.x
- 发表时间:2010-10
- 期刊:
- 影响因子:5.2
- 作者:Lemke G;Burstyn-Cohen T
- 通讯作者:Burstyn-Cohen T
TAM receptor signaling and autoimmune disease.
- DOI:10.1016/j.coi.2010.10.001
- 发表时间:2010-12
- 期刊:
- 影响因子:7
- 作者:Rothlin CV;Lemke G
- 通讯作者:Lemke G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Greg E Lemke其他文献
Greg E Lemke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Greg E Lemke', 18)}}的其他基金
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8615692 - 财政年份:2013
- 资助金额:
$ 46.92万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8856378 - 财政年份:2013
- 资助金额:
$ 46.92万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
9103238 - 财政年份:2013
- 资助金额:
$ 46.92万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
9278310 - 财政年份:2013
- 资助金额:
$ 46.92万 - 项目类别:
TAM receptor control of microglial function and nervous system homeostasis
TAM 受体控制小胶质细胞功能和神经系统稳态
- 批准号:
8732718 - 财政年份:2013
- 资助金额:
$ 46.92万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF 受体内吞作用:机制及其在信号传导中的作用
- 批准号:
10552100 - 财政年份:2023
- 资助金额:
$ 46.92万 - 项目类别:
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
- 批准号:
10677169 - 财政年份:2023
- 资助金额:
$ 46.92万 - 项目类别:
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
- 批准号:
10815443 - 财政年份:2023
- 资助金额:
$ 46.92万 - 项目类别:
ArpC3-mediated actin remodeling in insulin granule exocytosis and diabetes
ArpC3 介导的肌动蛋白重塑在胰岛素颗粒胞吐作用和糖尿病中的作用
- 批准号:
10583734 - 财政年份:2023
- 资助金额:
$ 46.92万 - 项目类别:
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 46.92万 - 项目类别: